Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: mature data from the randomised multicentre trial. CHART Steering committee (Q30584885)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: mature data from the randomised multicentre trial. CHART Steering committee	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 June 2017

Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: mature data from the randomised multicentre trial. CHART Steering committee (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 June 2017

multicenter clinical trial

0 references

adaptive radiation therapy

0 references

1 reference

based on heuristic

inferred from title

Gareth O Griffiths

1 reference

ORCID Public Data File 2021

author name string

Saunders M

1

1 reference

Europe PubMed Central

PubMed publication ID

25 June 2017

Dische S

2

1 reference

Europe PubMed Central

PubMed publication ID

25 June 2017

Barrett A

3

1 reference

Europe PubMed Central

PubMed publication ID

25 June 2017

Harvey A

4

1 reference

Europe PubMed Central

PubMed publication ID

25 June 2017

Griffiths G

5

1 reference

Europe PubMed Central

PubMed publication ID

25 June 2017

Palmar M

6

1 reference

Europe PubMed Central

PubMed publication ID

25 June 2017

publication date

1 August 1999

1 reference

Europe PubMed Central

PubMed publication ID

25 June 2017

Radiotherapy and Oncology

1 reference

Europe PubMed Central

PubMed publication ID

25 June 2017

52

1 reference

Europe PubMed Central

PubMed publication ID

25 June 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

25 June 2017

137-148

1 reference

Europe PubMed Central

PubMed publication ID

25 June 2017

Quality assurance in the CHART clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900087-0

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase III study of accelerated radiotherapy with and without carboplatin in nonsmall cell lung cancer: an interim toxicity analysis of the first 100 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900087-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of adding concurrent chemotherapy to hyperfractionated radiotherapy for locally advanced non-small cell lung cancer (NSCLC): comparison of RTOG 83-11 and RTOG 91-06.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900087-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Interruptions of high-dose radiation therapy decrease long-term survival of favorable patients with unresectable non-small cell carcinoma of the lung: analysis of 1244 cases from 3 Radiation Therapy Oncology Group (RTOG) trials

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900087-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Continuous, hyperfractionated, accelerated radiotherapy (CHART): an interim report upon late morbidity

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900087-0

7 January 2021

based on heuristic

inferred from DOI database lookup

The CHART regimen and morbidity

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900087-0

7 January 2021

based on heuristic

inferred from DOI database lookup

The rationale for continuous, hyperfractionated, accelerated radiotherapy (CHART).

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900087-0

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900087-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Costs of conventional radical radiotherapy versus continuous hyperfractionated accelerated radiotherapy (CHART) in the treatment of patients with head and neck cancer or carcinoma of the bronchus. Medical Research Council CHART Steering Committee

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900087-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Endpoints for multimodal clinical trials in stage III non-small cell lung cancer (NSCLC): a consensus report

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900087-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Induction cisplatin/vinblastine and irradiation vs. irradiation in unresectable squamous cell lung cancer: failure patterns by cell type in RTOG 88-08/ECOG 4588. Radiation Therapy Oncology Group. Eastern Cooperative Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900087-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: first analysis of a randomized trial in 353 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900087-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Thoracic radiation therapy alone compared with combined chemoradiotherapy for locally unresectable non-small cell lung cancer. A randomized, phase III trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900087-0

7 January 2021

based on heuristic

inferred from DOI database lookup

What now for postoperative radiotherapy for lung cancer?

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900087-0

7 January 2021

based on heuristic

inferred from DOI database lookup

The CHART trials: Bayesian design and monitoring in practice. CHART Steering Committee.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900087-0

7 January 2021

based on heuristic

inferred from DOI database lookup

A prospective randomized study of various irradiation doses and fractionation schedules in the treatment of inoperable non-oat-cell carcinoma of the lung. Preliminary report by the Radiation Therapy Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900087-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Overall treatment time and the conventional arm of the CHART trial in the radiotherapy of head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900087-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Radiotherapy employing three fractions in each day over a continuous period of 12 days

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900087-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Continuous, hyperfractionated, accelerated radiotherapy (CHART) in non-small cell carcinoma of the bronchus

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900087-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Is control of the primary tumour worthwhile in non-oat cell carcinoma of the bronchus

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900087-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised multicentre trials of CHART vs conventional radiotherapy in head and neck and non-small-cell lung cancer: an interim report. CHART Steering Committee

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900087-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: a randomised multicentre trial

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900087-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: preliminary results of a phase III trial in regionally advanced, unresectable non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900087-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and cost-effectiveness of cancer treatment: rational allocation of resources based on decision analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900087-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0167-8140(99)00087-0

1 reference

Europe PubMed Central

PubMed publication ID

25 June 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 June 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30584885&oldid=1577343723"